Safety and effectiveness of Hemay5087 for advanced solid tumors
Part of Cancer clinical trials.
This study tests a new experimental drug called Hemay5087 to see if it is safe and effective in treating advanced cancers that have not responded to standard treatments. Researchers will monitor your health closely and measure whether the cancer shrinks.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your cancer must be advanced and confirmed by a biopsy or tissue sample
- Standard treatments have not worked for you, or no standard treatment is available
- You must have at least one tumor spot that can be measured by CT or MRI scan
- At least 4 weeks have passed since your last cancer treatment, and side effects have mostly resolved
- Your overall health status must be good enough to participate (ECOG score 0–1)
- You are expected to live at least 3 more months
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new drug called HRS-7058 combined with other anti-tumor medicines for people with solid tumors. The goal is to see if the combination is safe and effective. It might be an option if you have advanced cancer and have not responded to other treatments.
This trial tests a new drug called HRS-6208 for people with advanced solid tumors that have stopped responding to standard treatments. It aims to see if the drug is safe and if it can help shrink or control the cancer.
This trial tests a new drug, Hemay181, for people with advanced solid tumors that have not responded to standard treatments. The goal is to see if it can shrink tumors and how safe it is.
This early-phase study (Phase 1) tests Hemay181, a new cancer medicine, in people with advanced solid tumors that have not been controlled by standard treatment. The goal is to see how the medicine works in the body and whether it can shrink or control tumors safely.
This trial tests a new drug called HRS-4508 for people with advanced or metastatic solid tumors that have not responded to standard treatments. The goal is to see if the drug is safe, how the body processes it, and if it helps shrink tumors.
This trial tests an experimental drug called MHB046C for people with advanced solid tumors that have stopped responding to standard treatments. The goal is to see if it can shrink tumors or slow their growth.
Hear when a new Solid Tumors trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.